個案總覽

Duke University Health System has for the past five years operated a specialized clinic for the management of congestive heart failure, a very common and costly condition in the surrounding community. Nurse practitioners, whose work is guided by highly specified protocols and overseen by cardiologists, staff the multidisciplinary clinic. The chancellor of the health system views the program as a huge financial burden and an undesirable use of academic cardiologists' time. The case examines models of disease management; Duke's heart failure program operations, finances, and outcomes of disease management; and the relationship between its nurse practitioners and cardiologists.

Mike Ramsey, TiVo's CEO, must decide on which direction to build the company. Facing an onslaught of new competitors, a huge opportunity in the cable industry, and the possibility of becoming the new "user interface" for TV entertainment, Ramsey must balance the demands for profitability with the hope of driving TiVo to mass adoption.

Focuses on the valuation of a complex option embedded in a convertible debenture with a negative yield to maturity.

BLES Biochemicals Inc., a research and development company, specializes in natural surfactants. After many years of trying, the president has finally obtained approval for the company's only product, BLES, which is used to help premature babies suffering from respiratory distress syndrome--without it, they could die. The company was able to sell the product in advance of receiving approval but with the news of receiving the go ahead, the president had to decide his next move. The obvious step was to pursue international expansion: The worldwide market potential for BLES was incredible. However, there were trade-offs associated with each of the markets under consideration. Moreover, the inherent risks associated with growth gave him cause for concern. He was anxious to develop a growth strategy that explicitly considered the interests of the company, prospective patients, his family, his partners, and his employees.

Supernova is the name given to a new way to manage client relationships that originated in the Merrill Lynch Indianapolis offices. During a trial period, Supernova generated very good results among financial advisers and their customers, but challenged the traditional ways in which financial advisers were rewarded and the nature of the relationship with their clients. The case protagonist needs to decide whether to recommend a national rollout for Supernova.

Pinnacle Technologies, although entirely independent, acts essentially as a subsidiary of U.K.-based Psion Teklogix. Psion Teklogix manufactures wireless data communications devices that are used primarily in inventory management activities performed in warehouses, ports, factories, and airports. In the mid-1990s, Psion gave Pinnacle Technologies exclusive Middle Eastern rights to the Teklogix technology and product line. It also assisted in training Pinnacle's development staff, programmers, and sales representatives. By 2002, Pinnacle was prospering and thinking of diversifying into related and unrelated software services. The CEO must decide to what degree Pinnacle should diversify from its core business and determine what financial and managerial resources are required for the diversification.

A seasoned health services entrepreneur develops a business plan for a cardiovascular-focused factory. Will it work?

Financial crises could happen anywhere, although emerging markets were more seriously afflicted in recent times. Debilitating and massive shocks to bank liquidity, payments systems, and solvency were obvious characteristics of financial crises, as was panic, which was often precipitated by a sudden and dramatic loss of depositor and investor confidence. Companies operating in a region where a financial crisis had broken out could undergo corporate disasters as a result. Provides a general description of financial crises and macroeconomic warning signs of them. Also describes three major financial crises in the late 1990s and early 2000s, how the business sectors of the regions were affected, and how some companies managed to ride out the crises.

Describes the rocky transition from an outdated, nonintegrated information system to a new customized system built by programmers in a small, IT-dependent foliage company that distributes plant material. The old system has increasingly become a "burning platform," but the project to build the new system is plagued by delays, the idiosyncrasies of the business, and lack of IT knowledge on the part of senior managers. The transition threatens to put the company out of business, and the crisis forces the COO to take charge of the project personally. After the new system goes live, however, it proves to be buggy and unreliable. The company comes even closer to collapse, and COO Penny Roberts must rally the team around an unpopular project whose success no one can guarantee. Teaching points include IT systems transition, IT management in small companies, and how to deal with an IT-based, business-interrupting disaster.

The Foundation for Informed Medical Decision-Making has created an interactive videodisc system that provides patients with customized support regarding medical treatment or screening decisions when they face a choice between two equally effective courses of action. The videodiscs, known as shared decision-making programs (SDPs), were the result of considering grant-funded research into treatment outcomes and patients' preferences concerning varying medical treatments. Over a six-year period, the foundation has partnered with a variety of commercial firms to manufacture and market the SDPs. Despite robust evidence supporting the effectiveness of the SDPs and the enthusiastic response of early purchasers, the foundation has been unable to widely disseminate the product and faces major debt.

Describes the 1949 firefighting tragedy in Montana that led to the deaths of 12 smoke jumpers. Explores the myriad of poor decisions by the firefighting crew and their foreman.

The hard-hitting "Truth" campaign has been one of the most successful antismoking initiatives in history. The focus of the "Truth" campaign is to dissuade teenagers from smoking. The sponsor of the campaign, the American Legacy Foundation, is now trying to decide whether to readjust its priorities and focus on what it calls "the other side of the equation"--encouraging already-addicted adult smokers to quit smoking. However, the only way to do this is by diverting resources away from the "Truth" campaign, a campaign that they know is working. Includes color exhibits.

In 2003, Rose Marie Bravo, Burberry's CEO, is debating how to maintain the currency and cachet of the brand across its broad customer base, while entering new product categories and expanding distribution. In the past five years, the brand has become one of the hottest luxury brands in the world. But Bravo now faces a number of key decisions, including (1) which new product categories to enter, (2) how to deal with the appropriation of the brand by nontarget customers, and (3) how prominent the company's famed "check" pattern should be in its advertising and clothing. Includes color exhibits.

As a proven entrepreneur, Rich Miner has been successful in the start-up world. Now, following the acquisition of his start-up, he has established a corporate R&D/venture operation in America to serve as the "eyes and ears" of his European parent company, Orange Telecom. He has resources that he never imagined, but getting Orange's attention is very hard to do.

Thirty years after its founding in 1973, New York City's Urban Homesteading Assistance Board (UHAB) found itself at a crossroads. The nonprofit, church-related organization that had long-provided tenants with assistance in renovating abandoned properties and converting them into cooperatives, UHAB was under pressure to adapt to a changing business climate, as the number of tax-foreclosed, city-owned properties declined in a resurgent New York city. What's more, UHAB, led by the same executive director for more than 20 years, faced tensions between an idealistic, semi-autonomous staff and the needs and demands of public contracts with requirements that specific tasks be completed in a measurably cost effective manner. As UHAB entered its fourth decade, a new chief operating officer must address its programmatic and managerial challenges, such that its idealism and individualism could happily co-exist with sound business practice. HKS Case Number 1711.0

Case A: Mark Chan worked for a British multinational in Singapore and was posted on an international assignment to its corporate headquarters in London. He performed well at his job and enjoyed a successful international career. When he and his wife decided to return home, he was unable to find a position that was requisite with his experience and skills back at the company's Singapore subsidiary. The case ends with Mark Chan wondering what he should do.

Technological and scientific innovation in recent years has opened up much research and development into renewable and alternative energies. Increasing pressure from environmental and governmental groups has led to the investigation of new and cleaner energy sources for the future. This case looks specifically at developments surrounding hydrogen-generated energy, focusing particularly on the possible benefits and market potential of such innovation and the challenges the industry might expect to encounter going forward.

Technological and scientific innovation in recent years has opened up much research, development and debate on the possibilities of colonizing other worlds. This case looks specifically at developments in the exploration of Mars, focusing particularly on the idea of inhabiting the planet, and the benefits and challenges this concept poses for the industry going forward.

Bryant Pharmaceutical's flagship product, a popular arthritis medicine called Seflex, is selling well--but not well enough. With generic versions due on the shelves in a couple of years, the drug company is looking for a dramatic sales increase. VP Laura Goldenberg knows she has to reach more consumers, but in an environment where people bombarded with advertising are using devices such as TiVo to skip ads, her job has suddenly taken on a new intensity. In search of a new, gangbuster campaign, Laura and her ad agency come up with the idea of product placement--not your typical integration of a product into a television or movie script, but a less traditional approach. Their idea is to hire a much-loved, elderly actress to extol the virtues of Seflex on a morning news program. The news segment would be about arthritis, and Seflex would be casually mentioned during the interview. The company would have to pay the actress $1 million, and there are risks: What if it gets out that Bryant is paying her? What if the actress errs and says something about Seflex's side effects? Should the company green-light Laura's plan? This fictional case study looks at the pros and cons of traditional product placement and newer, more subtle alternatives to advertising. Commenting on the case in R0310A and R0310Z, are Bob Gamgort, president of Masterfoods USA; Michelle R. Nelson, an assistant professor of journalism and mass communications at the University of Wisconsin, Madison; FTC commissioner Mozelle W. Thompson; and Mike Sheehan, president and CEO of Hill, Holliday, Connors, Cosmopulos.

Bryant Pharmaceutical's flagship product, a popular arthritis medicine called Seflex, is selling well--but not well enough. With generic versions due on the shelves in a couple of years, the drug company is looking for a dramatic sales increase. VP Laura Goldenberg knows she has to reach more consumers, but in an environment where people bombarded with advertising are using devices such as TiVo to skip ads, her job has suddenly taken on a new intensity. In search of a new, gangbuster campaign, Laura and her ad agency come up with the idea of product placement--not your typical integration of a product into a television or movie script, but a less traditional approach. Their idea is to hire a much-loved, elderly actress to extol the virtues of Seflex on a morning news program. The news segment would be about arthritis, and Seflex would be casually mentioned during the interview. The company would have to pay the actress $1 million, and there are risks: What if it gets out that Bryant is paying her? What if the actress errs and says something about Seflex's side effects? Should the company green-light Laura's plan? This fictional case study looks at the pros and cons of traditional product placement and newer, more subtle alternatives to advertising. Commenting on the case in R0310A and R0310Z, are Bob Gamgort, president of Masterfoods USA; Michelle R. Nelson, an assistant professor of journalism and mass communications at the University of Wisconsin, Madison; FTC commissioner Mozelle W. Thompson; and Mike Sheehan, president and CEO of Hill, Holliday, Connors, Cosmopulos.